Eindhoven, Netherlands

Johan Gerard Kleibeuker

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):

Title: Innovations in Drug Delivery: The Contributions of Johan Gerard Kleibeuker

Introduction

Johan Gerard Kleibeuker, an innovative inventor situated in Eindhoven, Netherlands, has made significant strides in the field of medical technology. With a focus on personalized drug delivery systems, Kleibeuker's contributions have the potential to transform how patients receive their medications. His invention revolves around a unique method of preparing swallowable capsules that incorporate advanced sensing capabilities.

Latest Patents

Kleibeuker holds a patent for a "Method of preparing a swallowable capsule comprising a sensor." This patent includes a kit that features a swallowable capsule equipped with a potentiometric sensor, such as a pH sensor, along with an unfilled electrolyte cell. The kit also contains a separate container for the liquid electrolyte, allowing for effective measurement through the sensor. The design ensures convenience, as it can be easily packed in a blister package, making it accessible for users.

Career Highlights

Currently, Johan Gerard Kleibeuker is associated with Medimetrics Personalized Drug Delivery B.V. His work at this company emphasizes developing cutting-edge drug delivery technologies that leverage personalized approaches, thereby enhancing patient compliance and therapeutic outcomes.

Collaborations

During his career, Kleibeuker has collaborated with esteemed colleagues, including Johan Frederik Dijksman and Anke Pierik. These collaborations have played a crucial role in advancing the research and development of innovative solutions in the pharmaceutical industry.

Conclusion

Johan Gerard Kleibeuker's inventive approach to swallowable capsules and drug delivery systems highlights the importance of innovation in healthcare. His patent and ongoing work with Medimetrics personalized drug delivery systems demonstrate a commitment to improving patient experiences and outcomes through technology. The future holds great promise as more advancements emerge from Kleibeuker and his collaborative efforts in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…